MTOR and cholangiocarcinoma: Dokduang et al. (2013) found that phosphorylated mTOR and its downstream effectors, p70S6K and 4E-BP1, were significantly increased in CCA tissues and cell lines, showing persistent activation of this pathway and its correlation with tumour aggressiveness and unfavourable prognosis [40].